Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mark Andrew Chambers (Mark A Chambers, Mark Chambers)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

University of Surrey

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Surrey Mar 2o 2020

United Kingdom

Professor of Microbiology and Disease Intervention :: Schools of Biosciences & Medicine and Veterinary Medicine

Education History

University of Cambridge

United Kingdom

PHD

Publications

Diane Frances Lee, David James Everest, William Cooley, Mark Andrew Chambers
Investigation of nasal epithelial cells as a surrogate for bronchial epithelial cells in the research of equine asthma. PloS one 18 (11) (2023)
Diane Frances Lee, Clare L Thompson, Ronald E Baynes, Hiroko Enomoto, Geof W Smith, Mark Andrew Chambers
Development and evaluation of a bovine lung-on-chip (bLOC) to study bovine respiratory diseases. In vitro models 1 (4-5) (2022)
Diane Frances Lee, Clare L Thompson, Ronald E Baynes, Hiroko Enomoto, Geof W Smith, Mark Andrew Chambers
Development and evaluation of a bovine lung-on-chip (bLOC) to study bovine respiratory diseases. In vitro models 1 (4-5) (2022)
Frederika Dicks, Tatjana Marks, Emilie Karafillakis, Mark Andrew Chambers
Vaccination as a Control Tool in Bovine Tuberculosis: Social Media Monitoring to Assess Public Response to Government Policy Development and Implementation. Vaccines 9 (4) (2021)
Rebecca Thomas, Mark Andrew Chambers
Review of Methods Used for Diagnosing Tuberculosis in Captive and Free-Ranging Non-Bovid Species (2012-2020). Pathogens (Basel, Switzerland) 10 (5) (2021)
Sandrine Lesellier, Colin P D Birch, Dipesh Davé, Deanna Dalley, Sonya Gowtage, Simonette Palmer, Claire McKenna, Gareth A Williams, Roland Ashford, Ute Weyer, Sarah Beatham, Julia Coats, Alex Nunez, Pedro J Sánchez-Cordón, John Spiropoulos, Stephen Powell, Jason Sawyer, Jordan Pascoe, Charlotte Hendon-Dunn, Joanna Bacon, Mark Andrew Chambers
Bioreactor-Grown Bacillus of Calmette and Guérin (BCG) Vaccine Protects Badgers against Virulent Mycobacterium bovis When Administered Orally: Identifying Limitations in Baited Vaccine Delivery. Pharmaceutics 12 (8) (2020)
Jordan Pascoe, Charlotte L Hendon-Dunn, Colin P D Birch, Gareth A Williams, Mark Andrew Chambers, Joanna Bacon
Optimisation of Mycobacterium bovis BCG Fermentation and Storage Survival. Pharmaceutics 12 (9) (2020)
Rachel E Butler, Alex A Smith, Tom A Mendum, Aneesh Chandran, Huihai Wu, Louise Lefrançois, Mark Andrew Chambers, Thierry Soldati, Graham R Stewart
Mycobacterium bovis uses the ESX-1 Type VII secretion system to escape predation by the soil-dwelling amoeba Dictyostelium discoideum. The ISME journal 14 (4) (2020)
Deanna Dalley, Sandrine Lesellier, Francisco Javier Salguero, Mark Andrew Chambers
Purification and Characterisation of Badger IgA and Its Detection in the Context of Tuberculosis. Veterinary sciences 6 (4) (2019)
Imran Y Saleem, Allan G A Coombes, Mark Andrew Chambers
In Vitro Evaluation of Eudragit Matrices for Oral Delivery of BCG Vaccine to Animals. Pharmaceutics 11 (6) (2019)
Diane Frances Lee, Mark Andrew Chambers
A bilayer tissue culture model of the bovine alveolus. F1000Research 8 (2019)
Diane Frances Lee, Mark Andrew Chambers
A bilayer tissue culture model of the bovine alveolus. F1000Research (2019)
Gareth A Williams, Marjorie E Koenen, Robert Havenaar, Paul Wheeler, Sonya Gowtage, Sandrine Lesellier, Mark Andrew Chambers
Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers. PloS one 14 (4) (2019)
Diane Frances Lee, Francisco Javier Salguero, Duncan Grainger, Robert James Francis, Kirsty MacLellan-Gibson, Mark Andrew Chambers
Isolation and characterisation of alveolar type II pneumocytes from adult bovine lung. Scientific reports 8 (1) (2018)

Mark Andrew Chambers.css-eqlu8i{font-size:small;padding-left:4px;} (Mark A Chambers, Mark Chambers)

Publication Activity (10 Years)

Top Topics

Top Venues

Mark Andrew Chambers (Mark A Chambers, Mark Chambers)